Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.22.2.2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Total KLA Stockholders’ Equity
Common Stock and Capital in Excess of Par Value, Shares
Common Stock and Capital in Excess of Par Value, Amount
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Non- Controlling Interest
Beginning balance (in shares) at Jun. 30, 2021     152,776        
Beginning balance at Jun. 30, 2021 $ 3,375,642 $ 3,377,554   $ 2,175,988 $ 1,277,123 $ (75,557) $ (1,912)
Increase (Decrease) in Stockholders' Equity              
Net income attributable to KLA 1,068,417 1,068,417     1,068,417    
Net income attributable to non-controlling interest 68           68
Other comprehensive loss (2,487) (2,487)       (2,487)  
Net issuance under employee stock plans (in shares)     160        
Net issuance under employee stock plans (46,532) (46,532)   (46,532)      
Repurchase of common stock (in shares)     (1,190)        
Repurchase of common stock (399,677) (399,677)   (16,966) (382,711)    
Cash dividends and dividend equivalents declared (161,561) (161,561)     (161,561)    
Stock-based compensation expense 25,216 25,216   25,216      
Ending balance (in shares) at Sep. 30, 2021     151,746        
Ending balance at Sep. 30, 2021 3,859,086 3,860,930   2,137,706 1,801,268 (78,044) (1,844)
Beginning balance (in shares) at Jun. 30, 2022     141,804        
Beginning balance at Jun. 30, 2022 1,399,090 1,401,351   1,061,940 366,882 (27,471) (2,261)
Increase (Decrease) in Stockholders' Equity              
Net income attributable to KLA 1,025,991 1,025,991     1,025,991    
Net income attributable to non-controlling interest 74           74
Other comprehensive loss (31,370) (31,370)       (31,370)  
Net issuance under employee stock plans (in shares)     171        
Net issuance under employee stock plans (54,950) (54,950)   (54,950)      
Repurchase of common stock (in shares)     (257)        
Repurchase of common stock (89,616) (89,616)   (1,926) (87,690)    
Cash dividends and dividend equivalents declared (186,216) (186,216)     (186,216)    
Stock-based compensation expense 34,982 34,982   34,982      
Purchase of non-controlling interest (4,294) 1,902   1,902     (6,196)
Disposal of non-controlling interest 8,383            
Ending balance (in shares) at Sep. 30, 2022     141,718        
Ending balance at Sep. 30, 2022 $ 2,102,074 $ 2,102,074   $ 1,041,948 $ 1,118,967 $ (58,841) $ 0